Introduction: Skin cancer is one of the most common neoplasms in Brazil, accounting for about 30% of malignant tumors, representing a significant public health challenge. In the State of Pará, factors such as high sun exposure and sociodemographic characteristics may influence the incidence and severity of this disease. Objective: To analyze the epidemiological profile of hospitalizations due to skin cancer in Pará from 2020 to 2024. Methods: This is a retrospective, descriptive, and quantitative study. The data used are available in the notification database of the Sistema Único de Saúde (SUS) - DATASUS, specifically from the SUS Hospital Information System (SIH/SUS). The collection included all hospitalizations in the State of Pará with a primary diagnosis of "malignant neoplasm of the skin" and "other malignant neoplasms of the skin" between January 2020 and December 2024. The following variables were analyzed: number of hospitalizations; year; age group; race; and deaths. Results: There were 2,192 hospitalizations during the period, with 1,244 (56.75%) being male. Regarding age group, 24.87% of the hospitalizations were among individuals aged 60 to 69 years, followed by those aged 70 to 79 years (24.68%). 81.6% of the hospitalized patients were identified as brown (pardo) race, and of the total number of hospitalizations, 161 deaths occurred. Conclusions: The predominance of hospitalizations in male patients may be related to factors such as higher occupational sun exposure and lower adherence to preventive measures, such as the use of sunscreen. The prevalence of cases in individuals of brown (pardo) race differs from the national pattern, where 62% of hospitalizations are among white individuals. This difference may be explained by the ethnic composition and economic disparities in the region. The higher incidence of hospitalizations in individuals aged 60 years or older highlights the importance of early diagnosis, preventive measures, and education directed towards this population.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
